Partial response to carboplatin in an RRx-001 pretreated patient with EGFR-inhibitor-resistance and T790M-negative NSCLC

Abstract Few therapeutic options are available for T790M-negative non-small cell lung cancer (NSCLC) after failure of primary epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) and chemotherapy. This report presents the case of a 71-year-old Asian female never smoker with EGFR m...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Respiratory medicine case reports 2016-01, Vol.18, p.62-65
Hauptverfasser:	Carter, Corey A, Oronsky, Bryan, Caroen, Scott, Scicinski, Jan, Cabrales, Pedro, Degesys, Aiste, Brzezniak, Christina
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report EGFR Episensitization Internal Medicine NSCLC Pulmonary/Respiratory RRx-001 T790 mutation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!